Masaki Mori
Masaki Mori, Ibaraki JP
Patent application number | Description | Published |
---|---|---|
20110023189 | TRANSFORMED PLANT WITH PROMOTED GROWTH - The present invention is directed to identify genes involved in the growth of a plant and provide a transformed plant the growth of which is promoted utilizing the genes. | 01-27-2011 |
20110258737 | RICE GENE CAPABLE OF IMPARTING WIDE-SPECTRUM DISEASE RESISTANCE - A three-step screening of selection for resistance against pathogenic bacteria infection, selection for resistance against pathogenic fungi infection, and selection for sensitivity to salicylic acid was carried out on | 10-20-2011 |
20130172189 | PLANT ACTIVATOR - A compound useful as a plant activator for activating an endogenous defense system of a plant to control disease damage is provided. A compound represented by the formula: (R | 07-04-2013 |
Masaki Mori, Kanagawa JP
Patent application number | Description | Published |
---|---|---|
20100292883 | Control device for guided travel of unmanned vehicle - A control device for guided travel of an unmanned vehicle, in which the unmanned vehicle is guided to travel by receiving a signal sent from a GPS satellite by the unmanned vehicle, measuring its own vehicle position based on the signal, and controlling such that a positional shift between the vehicle position and a target point that is a passing point sequentially set on a target traveling course falls into an allowable range for controlling error, wherein a guidable range is set in advance such that a position measurement error is added to the allowable range for controlling error; the position measurement error is obtained based on position measurement accuracy information from the signal; the allowable range for controlling error is changed according to the obtained position measurement error; and control is performed such that the positional shift falls into the changed allowable range for controlling error. | 11-18-2010 |
Masaki Mori, Kariya-Shi JP
Patent application number | Description | Published |
---|---|---|
20100001871 | COMMUNICATION ANOMALY DETECTING DEVICE, AND PASSENGER DETECTING DEVICE - An information request portion receives an information request signal transmitted to an information response portion at its own receiving port. The information request portion comprises at least either a power supply system anomaly determination portion or a ground anomaly determination portion. The power supply system anomaly determination portion determines a short-circuit between a signal line and a power supply system in a case where the information request signal received at the receiving port is always fixed to a H (high) level. The ground anomaly determination portion determines a short-circuit between a signal line and a ground in a case where the information request signal received at the receiving port is always fixed to a L (Low) level. Consequently, the anomaly region of the signal line connects the information request portion and the information response portion so that bidirectional digital communications are possible or the cause of the anomaly is specified. | 01-07-2010 |
20100066137 | POWER SEAT SYSTEM FOR VEHICLE - A power seat system for a vehicle, includes an operational switch configured to be operated by an occupant for changing positions and attitudes of a vehicle seat whose positions and attitudes are electrically adjusted, a sensor portion positioned in the vicinity of the operational switch and detecting a hand of the occupant approaching the operational switch without contacting the hand of the occupant, and a control portion changing the positions and attitudes of the vehicle seat by actuating an actuator on the basis of an output from the operational switch, the control portion configured to display an operational display indicating adjusting portions and directions of the vehicle seat, which is adjustable by means of the operational switch on the basis of the output from the sensor portion, at an display device provided in a vehicle. | 03-18-2010 |
Masaki Mori, Gifu JP
Patent application number | Description | Published |
---|---|---|
20090127904 | Seat Structure, Seat Extension/Retraction Method and Vehicle - In a seat ( | 05-21-2009 |
20090146477 | THICKNESS OF A SEAT CUSHION AT THE BACK SIDE OF A SEAT CUSHION FRAME - In a seat ( | 06-11-2009 |
20090302652 | Seat structure and seat contraction method - When a seat ( | 12-10-2009 |
20090322133 | Seat Structure and Vehicle - In a seat ( | 12-31-2009 |
Masaki Mori, Hyogo JP
Patent application number | Description | Published |
---|---|---|
20110222687 | APPARATUS AND METHOD FOR ENCRYPTING IMAGE DATA, AND DECRYPTING THE ENCRYPTED IMAGE DATA, AND IMAGE DATA DISTRIBUTION SYSTEM - An apparatus ( | 09-15-2011 |
Masaki Mori, Shizuoka-Ken JP
Patent application number | Description | Published |
---|---|---|
20120012079 | MULTI-CYLINDER ENGINE - A multi-cylinder engine with a crankcase integrated cylinder block including a cylinder block having a plurality of cylinder bores, a plurality of crank chambers formed by an upper crankcase and a lower crankcase, a bulkhead that partitions between the cylinder bores and the crank chambers, and a honing release portion having a cylindrical honing release surface formed continuously with the cylinder bore in the upper crankcase and the bulkhead. The honing release surface forms an arcuate recessed portion in the bulkhead, the bulkhead is formed with a communication hole that includes a first opening edge on a side of the cylinder bore, a second opening edge on a side of the crank chamber having an opening width decreasing with a distance from the cylinder bore, and a third opening edge that extends substantially in parallel with the cylinder axis. | 01-19-2012 |
Masaki Mori, Tajimi-Shi JP
Patent application number | Description | Published |
---|---|---|
20120274110 | Seat Structure and Vehicle - In a seat, in a state in which tilting of a back main frame around a tilting center is locked by a reclining mechanism, a lower end of a back joint link is turnably joined to a vehicle side. Thus, turning of a first link, a back sub frame and the back joint link is locked, and operation of a back link mechanism is locked. Therefore, a supporting rigidity from rear side of a back side portion can be enhanced by the back link mechanism (the back sub frame), and a crew sitting in the seat can be thoroughly retained. | 11-01-2012 |
20130292980 | SEAT STRUCTURE AND VEHICLE - In a seat, in a state in which tilting of a back main frame around a tilting center is locked by a reclining mechanism, a lower end of a back joint link is turnably joined to a vehicle side. Thus, turning of a first link, a back sub frame and the back joint link is locked, and operation of a back link mechanism is locked. Therefore, a supporting rigidity from rear side of a back side portion can be enhanced by the back link mechanism (the back sub frame), and a crew sitting in the seat can be thoroughly retained. | 11-07-2013 |
Masaki Mori, Daito-Shi JP
Patent application number | Description | Published |
---|---|---|
20120281149 | Mobile Terminal - A mobile device stores a TV application for serving as a remote control capable of controlling a TV receiver. The mobile device starts the process of starting the TV application and transmits, to the TV receiver, control signals to turn on the TV receiver before the TV application has been started. More particularly, the mobile device transmits the control signals to turn on the TV receiver while performing the process of starting the TV application. When the mobile device has started the TV application and then the TV receiver has been turned on in normal mode, a user can control the TV receiver by using the mobile device. | 11-08-2012 |
Masaki Mori, Osaka JP
Patent application number | Description | Published |
---|---|---|
20130065243 | METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS - A major object of the present invention is to provide a method for producing induced pluripotent stem cells with low tumorigenesis potential and high induction efficiency. | 03-14-2013 |
20130165340 | MULTIPLEX COLON CANCER MARKER PANEL - The present invention provides a specific combination of colon cancer markers based on statistical knowledge, which is capable of detecting a larger number of colon cancer patients in an earlier stage while maintaining high specificity. A multiplex colon cancer marker panel comprising a combination of five colon cancer markers of Carcinoembryonic antigen-related cell adhesion molecule 5, Carbohydrate antigen 19-9, Galectin-4, APEX nuclease and Actin-related protein 2. | 06-27-2013 |
20140302145 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER USING CARBONATE APATITE NANOPARTICLES - A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed. | 10-09-2014 |
Masaki Mori, Suita-Shi JP
Patent application number | Description | Published |
---|---|---|
20130065258 | COLORECTAL CANCER MARKER GALECTIN, METHOD FOR ANALYZING GALECTIN CONCENTRATION IN BLOOD SAMPLE, AND KIT FOR DETECTING COLORECTAL CANCER MARKER GALECTIN - The present invention provides a tumor screening marker that can be actually used in clinical practice to detect colorectal cancer, and a tumor progression marker that can complement CEA or CA19-9. Galectin-1 used as a tumor screening marker or a tumor progression marker for colorectal cancer. Galectin-3 used as a tumor screening marker. Galectin-4 used as a tumor progression marker, a tumor screening marker, or a prognostic prediction marker for colorectal cancer. A method of analyzing the galectin concentration in a collected blood sample using the galectin. A colorectal cancer marker detection kit comprising a detection antibody selected from the group consisting of a fluorescently labeled galectin-1 antibody, a fluorescently labeled galectin-3 antibody, and a fluorescently labeled galectin-4 antibody. | 03-14-2013 |
20130071864 | COLORECTAL CANCER MARKER VITRONECTIN AND METHOD FOR ANALYZING VITRONECTIN CONCENTRATION IN BLOOD SAMPLE - The present invention provides a tumor screening marker that can be actually used in clinical practice to detect colorectal cancer, and a tumor progression marker that can complement CEA or CA | 03-21-2013 |
20130171114 | ISLETS OF LANGERHANS TRANSPLANT USING ISLETS OF LANGERHANS AND ADIPOSE TISSUE DERIVED STEM CELLS - An object of the present invention is to provide a pancreatic islet transplantation technique that enables increase of graft survival rate of pancreatic islets after pancreatic islet transplantation, to maintain survival of pancreatic islets, and to reduce the number of transplanted pancreatic islets required for normalizing blood glucose level. When performing pancreatic islet transplantation, by transplanting pancreatic islets and adipose tissue-derived stem cells together, it is possible to significantly improve graft survival rate of transplanted pancreatic islets, and reduce by half the number of transplanted pancreatic islets required for normalizing blood glucose level. | 07-04-2013 |
20130177986 | PANCREATIC ISLET SEPARATION METHOD, AND PROTECTIVE SOLUTION FOR PROTECTING PANCREATIC ISLET TISSUE - The disclosed islet isolation method comprises: an injection step of injecting a preservation solution into the pancreatic duct of an excised pancreas; a preservation step of immersing the pancreas into an immersion fluid for preservation; a digestion step of breaking down the pancreas to provide pancreatic tissue; and a purification step of immersing the pancreatic tissue in a purification solution to provide islets. The digestion step consists of: an enzyme injection step of injecting an enzyme solution containing a digestion enzyme into the pancreas; a digestion initiation step of activating the digestion enzyme; a digestion termination step of inactivating the digestion enzyme; and a collection step of collecting the broken-down pancreatic tissue. The islet isolation method is characterized in that, by adding a neutrophil elastase inhibitor to the system before the digestion initiation step, the neutrophil elastase inhibitor is present inside the pancreas at the time point of starting the digestion initiation step. By using the above method and a protective solution which can be used in the method, islets having a size and shape suitable for transplantation can be obtained in high yields. | 07-11-2013 |
20140377768 | Novel Antitumor Agent and Method For Screening Same - The present invention provides a novel antitumor agent that acts through a novel mechanism. The novel antitumor agent contains as an active ingredient a substance capable of inhibiting a cell cycle-dependent Rho GTPase activating protein (RhoGAP). The RhoGAP is cell cycle-dependent and plays an important role in a process through which cancer cells acquire invasive capacity and/or metastatic capacity. The invasion and/or metastasis of cancer cells can be controlled by targeting the RhoGAP. Examples of the substance capable of inhibiting a cell cycle-dependent RhoGAP include an antisense oligonucleotide against a gene encoding the RhoGAP and an oligonucleotide that induces RNA interference of the gene. As the oligonucleotide, one containing an artificial nucleic acid such as BNA is preferred because of its excellent stability. The present invention also provides a screening method including selecting an antitumor agent capable of suppressing cancer cell invasion and/or metastasis through a novel mechanism. The screening method is a screening method for a novel antitumor agent, including selecting a substance capable of inhibiting a cell cycle-dependent Rho GTPase activating protein. | 12-25-2014 |
Masaki Mori US
Patent application number | Description | Published |
---|---|---|
20140302145 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER USING CARBONATE APATITE NANOPARTICLES - A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed. | 10-09-2014 |
Masaki Mori, Osaka-Shi JP
Patent application number | Description | Published |
---|---|---|
20150246301 | FILTERING APPARATUS, FILTER USED THEREIN , AND FILTER ELEMENT THEREOF - A filtering apparatus includes a cylindrical filter F having a cylinder axis in a vertical direction, and a casing C surrounding the filter F, in which untreated water a is filtered through the filter F from an outer circumferential surface to an inner circumferential surface of the filter F, and the resulting filtered water a′ is guided to the outside of the casing C. The filter F includes a plurality of divided filters arranged in the direction of the cylinder axis, and the divided filters can be easily repaired and replaced. The divided filters can be connected and integrated together via reinforcing rods | 09-03-2015 |